Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Decision Resources Group
Contact Force-Sensing Catheters Have Benefited From an Effort to Streamline Regulatory Process, According to Findings from Decision Resources Group
BURLINGTON, Mass., Aug. 20, 2014 /PRNewswire/ -- Decision Resources Group finds that the Japanese electrophysiology (EP) mapping and ablation device market will expand through 2023 as physicians increasingly use ablation to treat atrial fibrillation (AF). The increasing acceptance of ablation as a primary treatment option for AF will spur adoption of premium-priced products designed specifically for this application, such as advanced loop diagnostic catheters, cryoablation catheters and contact force-sensing ablation catheters. Overall, by 2023, the market will reach $1.1 billion.
Other key findings from Decision Resources Group's coverage of the Japanese EP mapping and ablation device market:
Comments from Decision Resources Group Analyst Roald Dhoska:
About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Decision Resources Group
©2012 PR Newswire. All Rights Reserved.